LONDON, Dec. 23, 2015 /PRNewswire/ -- This market insight presents an overview of the India contract research organization (CRO) market. It provides a revenue forecast for the market by phase and therapeutic type. The insight also discusses the major challenges, the unmet needs, and the emerging market trends. It analyzes the complete life cycle of the CRO market, from pre-clinical trials to post-marketing surveillance. This market insight offers in-depth information about support services, such as central laboratory testing, bioanalytics, and data management. It also analyzes Market Engineering measurements and research and development (R&D) trends.
Clinical Development Spending
In 2014, the Indian contract research organization (CRO) market generated a revenue of $ million. The market is expected to register a compound annual growth rate (CAGR) of %, reaching $ billion in 2019.
Clinical Development — Main Trends
- The market was poised to boom before the Indian Government implemented a slew of changes in regulations. This slowed growth as sponsors backed off and took their business to other emerging markets, such as China and Indonesia.
- Nevertheless, India is a market that cannot be ignored due to its large population and cost-effectiveness and will continue to attract investment.
MNCs and Local Pharmaceutical Companies
- Many global CROs are expanding their presence in Asia by opening up offices in the continent and forming alliances with local CROs. MNCs, such as Quintiles Inc and ICON, will continue to hold a significant presence in the market due to their reputation and experience.
- Local CROs also continue to expand their presence by offering more services and an in-depth knowledge of the regulations in the country.
Download the full report: https://www.reportbuyer.com/product/3180765/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48